Bryn Mawr Capital Management LLC Sells 5,349 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Bryn Mawr Capital Management LLC reduced its holdings in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 14.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,774 shares of the company's stock after selling 5,349 shares during the period. Bryn Mawr Capital Management LLC's holdings in Church & Dwight were worth $3,388,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of CHD. IAG Wealth Partners LLC lifted its stake in Church & Dwight by 92.9% in the 1st quarter. IAG Wealth Partners LLC now owns 270 shares of the company's stock worth $30,000 after acquiring an additional 130 shares in the last quarter. Bernard Wealth Management Corp. purchased a new stake in Church & Dwight in the 4th quarter worth about $40,000. Wayfinding Financial LLC purchased a new stake in Church & Dwight in the 1st quarter worth about $40,000. Versant Capital Management Inc lifted its stake in Church & Dwight by 42.1% in the 1st quarter. Versant Capital Management Inc now owns 378 shares of the company's stock worth $42,000 after acquiring an additional 112 shares in the last quarter. Finally, Banque Transatlantique SA purchased a new stake in shares of Church & Dwight during the 4th quarter worth about $46,000. 86.60% of the stock is owned by hedge funds and other institutional investors.

Church & Dwight Price Performance

CHD stock traded down $0.51 during trading on Friday, hitting $96.52. The company had a trading volume of 1,959,614 shares, compared to its average volume of 2,009,216. The company has a fifty day moving average price of $96.98 and a two-hundred day moving average price of $102.29. The company has a current ratio of 1.95, a quick ratio of 1.43 and a debt-to-equity ratio of 0.48. The company has a market cap of $23.77 billion, a P/E ratio of 41.43, a P/E/G ratio of 3.86 and a beta of 0.51. Church & Dwight Co., Inc. has a fifty-two week low of $90.99 and a fifty-two week high of $116.46.

Church & Dwight (NYSE:CHD - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.89 by $0.02. The business had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.52 billion. Church & Dwight had a return on equity of 19.28% and a net margin of 9.52%. Church & Dwight's quarterly revenue was down 2.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.96 EPS. Equities research analysts expect that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Thursday, May 15th were paid a $0.295 dividend. This represents a $1.18 annualized dividend and a yield of 1.22%. The ex-dividend date was Thursday, May 15th. Church & Dwight's dividend payout ratio is 50.64%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on CHD shares. Wells Fargo & Company raised their price target on Church & Dwight from $105.00 to $108.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 9th. Redburn Atlantic downgraded Church & Dwight from a "hold" rating to a "strong sell" rating in a research note on Monday. JPMorgan Chase & Co. cut their price target on Church & Dwight from $106.00 to $98.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. Barclays cut their price target on Church & Dwight from $94.00 to $84.00 and set an "underweight" rating for the company in a research note on Friday, May 2nd. Finally, Royal Bank Of Canada raised Church & Dwight from a "sector perform" rating to an "outperform" rating and raised their price target for the stock from $100.00 to $114.00 in a research note on Monday, June 2nd. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, Church & Dwight has a consensus rating of "Hold" and a consensus price target of $104.44.

Insider Buying and Selling

In other Church & Dwight news, Director Ravichandra Krishnamu Saligram sold 14,660 shares of the business's stock in a transaction on Friday, May 30th. The stock was sold at an average price of $99.00, for a total value of $1,451,340.00. Following the transaction, the director owned 13,747 shares of the company's stock, valued at approximately $1,360,953. The trade was a 51.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael Read acquired 3,000 shares of Church & Dwight stock in a transaction on Friday, May 9th. The stock was acquired at an average cost of $92.07 per share, for a total transaction of $276,210.00. Following the purchase, the executive vice president owned 5,505 shares of the company's stock, valued at approximately $506,845.35. This represents a 119.76% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have sold 50,575 shares of company stock valued at $4,910,586. Insiders own 2.00% of the company's stock.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.